Back to Awarded Treatment Trials
Awarded Trial: 03T-299
Grant ID
03T-299
Illness
Schizophrenia
Primary Drug/Intervention
LDXGW
Primary Dosage
9 gm twice a day
Secondary Drug Intervention
N/A
Secondary Dosage
N/A
Other Drug/Intervention
N/A
Other Dosage
N/A
Status
Completed
Investigator
Xu
Sample Size
200
Duration of Study Period for Each Subject
90 days
Outcome Measurements
BPRS, SANS, SAPS, CGI
Results
Patients were randomized to four groups: placebo only, LDXGW + risperidone 3-6 mg/day, LDXGW + risperidone < 3 mg/day, or risperidone only. The combination of LDXGW and risperidone showed a subtle benefit over the other two groups.
Publication
N/A
Link
N/A
PI Name
Zhiwei Xu
Degree
MD
Center
Guangzhou University of Traditional Chinese Medicine (TCM)
Institution
N/A
Address
No. 12 Jichang Road
City or Town
Guangzhou
State or Province
N/A
Zip or Postal Code
510405
Country
China
Email Address
xuzhiwei@gzhtcm.edu.cn